Pages that link to "Q34764885"

The following pages link to Cimetidine and gastric cancer: preliminary report from post-marketing surveillance study. (Q34764885):

Displaying 19 items.

• Peptic ulcer, cimetidine, and motor neurone disease--a record linkage study (Q34377714) (← links)
• Use of cimetidine and other peptic ulcer drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users (Q34396057) (← links)
• Postmarketing surveillance of the safety of cimetidine: 10 year mortality report (Q34396195) (← links)
• Post marketing surveillance of captopril (for hypertension): a preliminary report (Q34416830) (← links)
• Post-marketing surveillance in the UK (1984). (Q34447582) (← links)
• Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up (Q34487626) (← links)
• Comparison of different strategies for treatment of duodenal ulcer (Q34492441) (← links)
• Cancer occurrence in a cohort of patients treated with cimetidine (Q34532561) (← links)
• Postmarketing surveillance of the safety of cimetidine: 12 month mortality report (Q34993287) (← links)
• Routine practice in the diagnosis of adenocarcinoma of the stomach: a survey of tumours diagnosed in the Portsmouth and Oxford Health Districts 1979-1980. (Q36722171) (← links)
• Relationship between gastric secretion and infection (Q39758320) (← links)
• Assessing the safety of drugs for the long-term treatment of peptic ulcers (Q40096115) (← links)
• Safety of acid-suppressing drugs (Q40595584) (← links)
• Antisecretory drugs and gastric cancer (Q41820551) (← links)
• Gastric microflora. (Q41892823) (← links)
• Habit, prejudice, power and politics: issues in the conversion of H2-receptor antagonists to over-the-counter use. (Q42378720) (← links)
• The refractory ulcer. (Q54405498) (← links)
• European postmarketing surveillance of ramipril in hypertension. 1. Feasibility and study cohort (Q71378066) (← links)
• Publications: Professor Martin Vessey (Q74759854) (← links)